FOCUS-Takeda CEO prescribes surgical R&D cuts after $62 bln Shire deal By: Reuters: Company News May 17, 2018 at 08:10 AM EDT * Takeda boss to raise bar for pipeline drugs after Shire deal Read More >> Related Stocks: Bay National Corp Gsk Plc ADR Monsanto Co Novan Inc Pfizer Shoal Point Energy Ltd